Examining the Volatility of Genprex Inc.’s (GNPX) Stock

The stock of Genprex Inc. (GNPX) has gone down by -13.46% for the week, with a -18.66% drop in the past month and a -45.91% drop in the past quarter. The volatility ratio for the week is 6.86%, and the volatility levels for the past 30 days are 9.11% for GNPX. The simple moving average for the past 20 days is -11.57% for GNPX’s stock, with a -54.27% simple moving average for the past 200 days.

Is It Worth Investing in Genprex Inc. (NASDAQ: GNPX) Right Now?

Additionally, the 36-month beta value for GNPX is -0.15. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”

The average price predicted by analysts for GNPX is $3.00, which is $7.55 above the current price. The public float for GNPX is 57.79M and currently, short sellers hold a 2.96% ratio of that float. The average trading volume of GNPX on September 19, 2023 was 717.04K shares.

GNPX) stock’s latest price update

Genprex Inc. (NASDAQ: GNPX)’s stock price has dropped by -12.54 in relation to previous closing price of 0.51. Nevertheless, the company has seen a loss of -13.46% in its stock price over the last five trading days. Zacks Investment Research reported 2023-09-04 that GENPREX (GNPX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.

Analysts’ Opinion of GNPX

Many brokerage firms have already submitted their reports for GNPX stocks, with National Securities repeating the rating for GNPX by listing it as a “Buy.” The predicted price for GNPX in the upcoming period, according to National Securities is $7 based on the research report published on January 26, 2021 of the previous year 2021.

GNPX Trading at -31.78% from the 50-Day Moving Average

After a stumble in the market that brought GNPX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.03% of loss for the given period.

Volatility was left at 9.11%, however, over the last 30 days, the volatility rate increased by 6.86%, as shares sank -13.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -48.78% lower at present.

During the last 5 trading sessions, GNPX fell by -13.46%, which changed the moving average for the period of 200-days by -65.98% in comparison to the 20-day moving average, which settled at $0.5005. In addition, Genprex Inc. saw -69.27% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GNPX starting from VACZY CATHERINE M, who purchase 20,000 shares at the price of $1.07 back on Apr 21. After this action, VACZY CATHERINE M now owns 265,000 shares of Genprex Inc., valued at $21,478 using the latest closing price.

Varner John Rodney, the Chairman, President and CEO of Genprex Inc., purchase 19,000 shares at $1.05 during a trade that took place back on Apr 21, which means that Varner John Rodney is holding 20,800 shares at $20,045 based on the most recent closing price.

Stock Fundamentals for GNPX

The total capital return value is set at -75.00, while invested capital returns managed to touch -74.71. Equity return is now at value -149.60, with -127.40 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 7.64.

Conclusion

In conclusion, Genprex Inc. (GNPX) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.